Invasive circuitry-based neurotherapeutics: Stereotactic ablation and deep brain stimulation for OCD

Neuropsychopharmacology

Volumn 35, Issue 1, 2010, Pages 317-336

  Greenberg, Benjamin D ^a   Rauch, Scott L ^b   Haber, Suzanne N ^c  

^a BROWN UNIVERSITY   (United States)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Ablation; Biological psychiatry; Deep brain stimulation; Gamma knife; Neurosurgery; Obsessive compulsive disorder

Indexed keywords

CYCLOSERINE; SEROTONIN UPTAKE INHIBITOR;

AUDIOVISUAL EQUIPMENT; BASAL GANGLION; BEHAVIOR THERAPY; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; CAPSULOTOMY; CINGULECTOMY; CLINICAL FEATURE; COGNITION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LIMBIC LEUKOTOMY; MOTOR DYSFUNCTION; NEUROCHEMISTRY; NEUROIMAGING; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PATHOPHYSIOLOGY; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHIATRIST; REVIEW; STEREOTAXIC SURGERY; SUBCAUDATE TRACTOTOMY; SURGICAL TECHNIQUE; THALAMUS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ABLATION TECHNIQUES; ANIMALS; BRAIN; DEEP BRAIN STIMULATION; HUMANS; NEURAL PATHWAYS; NEUROSURGICAL PROCEDURES; OBSESSIVE-COMPULSIVE DISORDER; STEREOTAXIC TECHNIQUES;

EID: 72049132090     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.128     Document Type: Review

References (167)

1. Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF et al (2005). Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 57: 510-516.
2. Albucher RC, Curtis GC, Pitts K (1999). Neurosurgery for obsessive-compulsive disorder: problems with comorbidity. Am J Psychiatry 156: 495-496.
3. Aouizerate B, Cuny E, Martin-Guehl C, Guehl D, Amieva H, Benazzouz A et al (2004). Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 101: 682-686.
4. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
5. Arnold PD, Macmaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E et al (2009). Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res 172: 136-139.
6. Baer L (1994). Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 55(Suppl): 18-23.
7. Ballantine Jr HT, Bouckoms AJ, Thomas EK, Giriunas IE (1987). Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry 22: 807-819.
8. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Zohar J et al (2008). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disordersFfirst revision. World J Biol Psychiatry 9: 248-312.
9. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM (2002). Response inhibition deficits in obsessive-compulsive disorder. Psychiatry Res 110: 165-174.
10. Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RWJ, Carr TJ et al (1998). A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 155: 1584-1591.
11. Baxter Jr LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC et al (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49: 681-689. An important early publication using neuroimaging to delineate neurocir-cuitry putatively involved in OCD pathophysiology.
12. Beck DM, Kastner S (2009). Top-down and bottom-up mechanisms in biasing competition in the human brain. Vision Res 49: 1154-1165.
13. Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009). Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 8: 67-81. The most comprehensive series of cases describing outcomes and adverse effects in DBS for movement disorders.
14. Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR (1989). Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Arch Gen Psychiatry 46: 23-28.
15. Binder DK, Iskandar BJ (2000). Modern neurosurgery for psychiatric disorders. Neurosurgery 47: 9-21; discussion 21-23.
16. Bingley T, Leksell L, Meyerson BA, Rylander G (1977). Long term results of stereotactic capsulotomy in chronic obsessive-compulsive neurosis. In: Sweet WH, Obrador Alcalde S, Martín-Rodríguez JG (eds). Neurosurgical Treatment in Psychiatry, Pain, and Epilepsy. Proceedings of the Fourth World Congress of Psychiatric Surgery; 7-10 September 1975, Madrid, Spain University Park Press: Baltimore. pp 287-299.
17. Blier P, Habib R, Flament MF (2006). Pharmacotherapies in the management of obsessive-compulsive disorder. Can J Psychiatry 51: 417-430.
18. Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF (2008). Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 165: 1532-1542.
19. Bridges PK, Bartlett JR, Hale AS, Poynton AM, Malizia AL, Hodgkiss AD (1994). Psychosurgery: stereotactic subcaudate tractomy. An indispensable treatment. Br J Psychiatry 165: 599-611; discussion 612-1593
20. Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME et al (1998). FDG-PET predictors of response to behavioral therapy and pharma-cotherapy in obsessive-compulsive disorder. Psychiatry Res 84: 1-6. An important example of response prediction using PET in OCD.
21. Cannistraro PA, Makris N, Howard JD, Wedig MM, Hodge SM, Wilhelm S et al (2007). A diffusion tensor imaging study of white matter in obsessive-compulsive disorder. Depress Anxiety 24: 440-446.
22. Cecconi JP, Lopes AC, Duran FL, Santos LC, Hoexter MQ, Gentil AF et al (2008). Gamma ventral capsulotomy for treatment of resistant obsessive-compulsive disorder: a structural MRI pilot prospective study. Neurosci Lett 447: 138-142.
23. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ (2005). The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 29: 399-419. A heuristically valuable study of putative OCD endophenotypes.
24. Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW et al (2007). Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry 164: 335-338.
25. Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, del Campo N et al (2008). Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 321: 421-422.
26. Chang JY, Shi LH, Luo F, Zhang WM, Woodward DJ (2007). Studies of the neural mechanisms of deep brain stimulation in rodent models of Parkinson's disease. Neurosci Biobehav Rev 31: 643-657.
27. Cho DY, Lee WY, Chen CC (2008). Limbic leukotomy for intractable major affective disorders: a 7-year follow-up study using nine comprehensive psychiatric test evaluations. J Clin Neurosci 15: 138-142.
28. Cohen RM, Gross M, Nordahl TE, Semple WE, Oren DA, Rosenthal N (1992). Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry 49: 545-552.
29. Coles ME, Heimberg RG, Frost RO, Steketee G (2005). Not just right experiences and obsessive-compulsive features: experimental and self-monitoring perspectives. Behav Res Ther 43: 153-167.
30. Corchs F, Corregiari F, Ferrao YA, Takakura T, Mathis ME, Lopes AC et al (2008). Personality traits and treatment outcome in obsessive-compulsive disorder. Rev Bras Psiquiatr 30: 246-250.
31. Cosgrove GR (2000). Surgery for psychiatric disorders. CNS Spectr 5: 43-52.
32. Denys D, Burger H, van Megen H, de Geus F, Westenberg H (2003). A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 18: 315-322.
33. Denys D, de Geus F (2005). Predictors of pharmacotherapy response in anxiety disorders. Curr Psychiatry Rep 7: 252-257.
34. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H (2006). Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol 16: 446-450.
35. Denys D, Zohar J, Westenberg HG (2004). The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 65(Suppl 14): 11-17. An influential statement of potential involvement of dopaminergic mechanisms in OCD.
36. Dougherty DD, Baer L, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA et al (2002). Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry 159: 269-275. A key study of cingulotomy for OCD using modern diagnoses and assessment methods.
37. Dougherty DD, Rauch SL, Jenike MA (2004). Pharmacotherapy for obsessive-compulsive disorder. J Clin Psychol 60: 1195-1202.
38. Dougherty DD, Weiss AP, Cosgrove GR, Alpert NM, Cassem EH, Nierenberg AA et al (2003). Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg 99: 1010-1017.
39. Ebert D, Speck O, Konig A, Berger M, Hennig J, Hohagen F (1997). 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 74: 173-176.
40. Eddy KT, Dutra L, Bradley R, Westen D (2004). A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev 24: 1011-1030.
41. Eisen JL, Mancebo MA, Pinto A, Coles ME, Pagano ME, Stout R et al (2006). Impact of obsessive-compulsive disorder on quality of life. Compr Psychiatry 47: 270-275. An early systematic study of outcomes beyond symptom severity in OCD.
42. El Mansari M, Blier P (2005). Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition. J Psychiatry Neurosci 30: 268-274.
43. El-Hai J (2005). The Lobotomist: A Maverick Medical Genius and His Tragic Quest to Rid the World of Mental Illness. J. Wiley: Hoboken, N.J.
44. Feldman RP, Alterman RL, Goodrich JT (2001). Contemporary psychosurgery and a look to the future. J Neurosurg 95: 944-956.
45. Fins JJ (2003). From psychosurgery to neuromodulation and palliation: history's lessons for the ethical conduct and regulation of neuropsychiatric research. Neurosurg Clin North Am 14: 303-319, ix-x.
46. Fins JJ, Rezai AR, Greenberg BD (2006). Psychosurgery: avoiding an ethical redux while advancing a therapeutic future. Neurosurgery 59: 713-716. An updated statement of ethical recommendation for the field of psychiatric neuro-surgery from authors of the original DBS for OCD Collaborative Group statement on this issue.
47. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME et al (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 162: 151-161. A landmark study comparing behavioral and medication treatments.
48. Freeman W, Watts JW, Hunt T (1942). Psychosurgery; Intelligence, Emotion And Social Behavior Following Prefrontal Lobotomy For Mental Disorders. Charles C. Thomas: Springfield, Ill. Early systematic research in several outcome domains from Freeman and colleagues. Freeman later became an 'evangalist' for lobotomy, an enduring caution to the field.
49. Gabriels L, Cosyns P, Nuttin B, Demeulemeester H, Gybels J (2003). Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psycho-pathological and neuropsychological outcome in three cases. Acta Psychiatr Scand 107: 275-282.
50. Gabriels L, Nuttin B, Cosyns P (2008). Applicants for stereotactic neurosurgery for psychiatric disorders: role of the Flemish advisory board. Acta Psychiatr Scand 117: 381-389. A very important study of appropriate and inappropriate referrals for psychiatric neurosurgery.
51. Gilbert AR, Keshavan MS, Diwadkar V, Nutche J, Macmaster F, Easter PC et al (2008). Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett 435: 45-50.
52. Goodman WK, Insel TR (2009). Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry 65: 263-266. The most recent statement considering science, treatment, and policy in this are from the NIMH.
53. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46: 1006-1011.
54. Grados MA, Riddle MA (2008). Two times four is four: OCD dimensions, classes, and categories. J Am Acad Child Adolesc Psychiatry 47: 731-733.
55. Greenberg BD, Altemus M, Murphy DL (1997). The role of neurotransmitters and neuropeptides in obsessive-compulsive disorder. Int Rev Psychiatry 9: 31-34.
56. Greenberg BD, Benjamin J, Martin JD, Keuler D, Huang SJ, Altemus M et al (1998). Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients. Psychopharmacology (Berl) 140: 434-444.
57. Greenberg BD, Dougherty DD, Rauch SL (in press). Neurosurgical treatments: lesion procedures and deep brain stimulation. In: Sadock BJ, Sadock VA, Ruiz P (eds). Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 9th edn. Lippincott, Williams & Wilkins: Philadelphia. pp 3314-3322.
58. Greenberg BD, Gabriels LA, Malone DA, Rezai AR, Friehs GM, Okun MS et al (2008). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Molecular Psychiatry, E-pub ahead of print. The most comprehensive presentation of technique and results of DBS at the VC/VS target for OCD.
59. Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF et al (2006). Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 31: 2384-2393.
60. Greenberg BD, Nuttin B, Rezai AR (2006). Education and neuromodulation for psychiatric disorders: a perspective for practitioners. Neurosurgery 59: 717-719.
61. Greenberg BD, Price LH, Rauch SL, Jenike MA, Malone D, Friehs G et al (2003). Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin North Am 14: 199-212. A comprehensive review of lesion procedures for OCD or depression.
62. Grill WM, Cantrell MB, Robertson MS (2007). Antidromic propagation of action potentials in branched axons: implications for the mechanisms of action of deep brain stimulation. J Comput Neurosci 24: 81-93.
63. Haber SN, Kim KS, Mailly P, Calzavara R (2006). Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical inputs, providing a substrate for incentive-based learning. J Neurosci 26: 8368-8376.
64. Haber S, Knutson B (2009, in press). The reward circuit and risky behavior (a macroview). Neuropsychopharmacol.
65. Hay P, Sachdev P, Cumming S, Smith JS, Lee T, Kitchener P et al (1993). Treatment of obsessive-compulsive disorder by psychosurgery. Acta Psychiat Scand 87: 197-207.
66. Herner T (1961). Treatment of mental disorders with frontal stereotactic thermo-lesions: a follow-up of 116 cases. Acta Psychiatr Scand 58(suppl 36): 1-140.
67. Hong JP, Samuels J, Bienvenu III OJ, Cannistraro P, Grados M, Riddle MA et al (2004). Clinical correlates of recurrent major depression in obsessive-compulsive disorder. Depress Anxiety 20: 86-91.
68. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78: 815-826.
69. Huey ED, Zahn R, Krueger F, Moll J, Kapogiannis D, Wassermann EM et al (2008). A psychological and neuroanatomical model of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 20: 390-408.
70. Husted DS, Shapira NA (2004). A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation. CNS Spectr 9: 833-847.
71. Jenike MA, Breiter HC, Baer L, Kennedy DN, Savage CR, Olivares MJ et al (1996). Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 53: 625-632.
72. Kathmann N, Rupertseder C, Hauke W, Zaudig M (2005). Implicit sequence learning in obsessive-compulsive disorder: further support for the fronto-striatal dysfunction model. Biol Psychiatry 58: 239-244.
73. Kelly D, Richardson A, Mitchell-Heggs N, Greenup J, Chen C, Hafner RJ (1973). Stereotactic limbic leucotomy: a preliminary report on forty patients. Br J Psychiatry 123: 141-148.
74. Kemp JM, Powell TPS (1970). The cortico-striate projections in the monkey. Brain 93: 525-546.
75. Kim CH, Chang JW, Koo MS, Kim JW, Suh HS, Park IH et al (2003). Anterior cingulotomy for refractory obsessive-compulsive disorder. Acta Psychiatr Scand 107: 283-290.
76. Kim MC, Lee TK, Choi CR (2002). Review of long-term results of stereotactic psychosurgery. Neurol Med Chir (Tokyo) 42: 365-371.
77. Knight G (1973). Further observations from an experience of 660 cases of stereotactic tractotomy. Postgrad Med J 49: 845-854.
78. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ (1998). Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psychopharmacology (Berl) 136: 205-216.
79. Koran LM (1999). Obsessive-Compulsive and Related Disorders in Adults: a Comprehensive Clinical Guide. Cambridge Univ. Press: Cambridge.
80. Kullberg G (1977). Differences in effects of capsulotomy and cingulotomy. In: Sweet WH, Obrador WS, Martín-Rodríguez JG (eds). Neurosurgical Treatment in Psychiatry, Pain and Epilepsy. University Park Press: Baltimore. pp 208-301.
81. Lappin JM, Reeves SJ, Mehta MA, Egerton A, Coulson M, Grasby PM (2009). Dopamine release in the human striatum: motor and cognitive tasks revisited. J Cereb Blood Flow Metab 29: 554-564.
82. Leckman JF, Zhang H, Alsobrook JP, Pauls DL (2001). Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. Am J Med Genet 105: 28-30. An early and influential statement about differences in OCD symptom dimensions that has inspired clinical and neuroimaging research.
83. Lehericy S, Ducros M, Van de Moortele PF, Francois C, Thivard L, Poupon C et al (2004). Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann Neurol 55: 522-529. (Pubitemid 38391969)
84. Lippitz BE, Mindus P, Meyerson BA, Kihlstrom L, Lindquist C (1999). Lesion topography and outcome after thermocapsulotomy or gamma knife capsulotomy for obsessive-compulsive disorder: relevance of the right hemisphere. Neurosurgery 44: 452-458; discussion 458-460.
85. Lopes AC, Greenberg BD, Noren G, Canteras MM, Busatto G, Mathis M et al (2009, in press). Treatment of resistant obsessive-compulsive disorder with ventral capsular/ventral striatal gamma capsulotomy: a pilot prospective study. J Neuropsychiatry Clin Neurosci. The first controlled trial of an ablative procedure in psychiatry, underway as of this writing, is described here.
86. Makris N, Papadimitriou GM, Kaiser JR, Sorg S, Kennedy DN, Pandya DN (2009). Delineation of the middle longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. Cereb Cortex 19: 777-785.
87. Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D et al (2008). Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 359: 2121-2134. The first trial of DBS of the STN for OCD.
88. Malone Jr DA, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN et al (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 65: 267-275. The first trial of DBS of the VC/VS for intractable depression.
89. Mancebo MC, Eisen JL, Pinto A, Greenberg BD, Dyck IR, Rasmussen SA (2006). The Brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement. J Clin Psychiatry 67: 1713-1720.
90. Mancebo MC, Greenberg B, Grant JE, Pinto A, Eisen JL, Dyck I et al (2008). Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder. Compr Psychiatry 49: 43-50.
91. Mansari ME, Bouchard C, Blier P (1995). Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Neuropsychopharmacol 13: 117-127. An early study integrating anatomical and pharmacological perspectives within putative OCD neurocircuitry in the rodent.
92. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML (2004). Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 61: 564-576.
93. McCracken CB, Grace AA (2007). High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. J Neurosci 27: 12601-12610.
94. McCracken CB, Grace AA (2009). Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. J Neurosci 29: 5354-5363. Two groundbreaking studies of potential physiological mechanisms of action of stimulation analogous to DBS at the VC/VS in the rodent.
95. McFarland NR, Haber SN (2002). Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. J Neurosci 22: 8117-8132.
96. McGuire PK, Bench CJ, Frith CD, Marks IM, Frackowiak RS, Dolan RJ (1994). Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 164: 459-468.
97. Mindus P, Bergstrom K, Thuomas KA, Hindmarsh T (1986). Magnetic resonance imaging of stereotactic radiosurgical lesions in the internal capsule. Acta Radiol Suppl 369: 614-617.
98. Mindus P, Ericson K, Greitz T (1986). Regional cerebral glucose metabolism in anxiety disorders studied with positron emission tomography before and after psychosurgical intervention. A preliminary report. Acta Radiol Suppl 369: 444-448.
99. Mindus P, Rasmussen SA, Lindquist C (1994). Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. J Neuropsychiatry Clin Neurosci 6: 467-477.
100. Montgomery Jr EB, Baker KB (2000). Mechanisms of deep brain stimulation and future technical developments. Neurol Res 22: 259-266.
101. Mufson EJ, Pandya DN (1984). Some observations on the course and composition of the cingulum bundle in the rhesus monkey. J Comp Neurol 225: 31-43.
102. Murray CJ, Lopez AD (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442.
103. National Commission (1977). Psychosurgery: Report and Recommendations. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: [Bethesda, Md.], United States.
104. Nestadt G, Addington A, Samuels J, Liang KY, Bienvenu OJ, Riddle M et al (2003). The identification of OCD-related subgroups based on comorbidity. Biol Psychiatry 53: 914-920.
105. Nestadt G, Samuels J, Riddle M, Bienvenu III OJ, Liang KY, LaBuda M et al (2000). A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 57: 358-363.
106. Nestadt G, Samuels J, Riddle MA, Liang KY, Bienvenu OJ, Hoehn-Saric R et al (2001). The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med 31: 481-487. (Pubitemid 32294046)
107. New York Times (1937). Surgery used on the soul-sick; relief of obsessions is reported. New York Times, Page 1. Both the enthusiasm and skepticism about surgery in psychiatry in an earlier age are exemplified here.
108. Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B (1999). Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 354: 1526. The first modern use of DBS in psychiatry.
109. Nuttin BJ, Gabriels LA, Cosyns PR, Meyerson BA, Andreewitch S, Sunaert SG et al (2008). Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery 62(6 Suppl 3): 966-977.
110. OCD-DBS Collaborative Group (2002). Deep brain stimulation for psychiatric disorders. Neurosurgery 51: 519.
111. Okun MS, Bowers D, Springer U, Shapira NA, Malone D, Rezai AR et al (2004). What's in a 'smile?' Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase 10: 271-279.
112. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J et al (2003). Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8: 933-936. (Pubitemid 37421700)
113. Pan HC, Sheehan J, Stroila M, Steiner M, Steiner L (2005). Late cyst formation following gamma knife surgery of arteriovenous malformations. J Neurosurg 102(Suppl): 124-127.
114. Perani D, Garibotto V, Gorini A, Moresco RM, Henin M, Panzacchi A et al (2008). In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage 42: 306-314.
115. Petrides M, Pandya DN (2007). Efferent association pathways from the rostral prefrontal cortex in the macaque monkey. J Neurosci 27: 11573-11586.
116. Phillips ML, Marks IM, Senior C, Lythgoe D, O'Dwyer AM, Meehan O et al (2000). A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med 30: 1037-1050.
117. Pinto A, Greenberg BD, Grados MA, Bienvenu III OJ, Samuels JF, Murphy DL et al (2008). Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories. Psychiatry Res 160: 83-93.
118. Pinto A, Mancebo MC, Eisen JL, Pagano ME, Rasmussen SA (2006). The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry 67: 703-711.
119. Pool JL (1954). Psychosurgery in older people. J Am Geriatr Soc 7: 456-466.
120. Pressman JD (1998). Last Resort: Psychosurgery and the Limits of Medicine. Cambridge University Press: Cambridge, UK; New York, NY.
121. Price BH, Baral I, Cosgrove GR, Rauch SL, Nierenberg AA, Jenike MA et al (2001). Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases. J Clin Psychiatry 62: 925-932.
122. Rabins PV, Appleby BS, Brandt J, DeLong MR, Dunn LB, Gabriëls L et al (in press). Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior and thought. Arch Gen Psychiatry.
123. Rasmussen SA, Eisen JL (1992). The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am 15: 743-758.
124. Rasmussen SA, Eisen JL (1994). The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry 55(Suppl): 5-10; discussion 11-14.
125. Rauch SL (2003). Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurg Clin N Am 14: 213-223, vii-viii.
126. Rauch SL, Dougherty DD, Cosgrove GR, Cassem EH, Alpert NM, Price BH et al (2001a). Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry 50: 659-667.
127. Rauch SL, Dougherty DD, Malone D, Rezai A, Friehs G, Fischman AJ et al (2006). A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg 104: 558-565. These two studies exemplify the potential utility of neuroimaging in response prediction and in probing neural networks modulated by DBS, respectively.
128. Rauch SL, Dougherty DD, Shin LM, Albert N, Manzo P, Leahy L et al (1998). Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectr 3: 37-43.
129. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR et al (1994). Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51: 62-70.
130. Rauch SL, Kim H, Makris N, Cosgrove GR, Cassem EH, Savage CR et al (2000). Volume reduction in caudate nucleus following stereotactic lesions of anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. J Neurosurgery 93: 1019-1025.
131. Rauch SL, Makris N, Cosgrove GR, Kim H, Cassem EH, Price BH et al (2001b). A magnetic resonance imaging study of regional cortical volumes following stereotactic anterior cingulotomy. CNS Spectrums 6: 214-222.
132. Rauch SL, Savage CR, Alpert NM, Dougherty D, Kendrick A, Curran T et al (1997). Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci 9: 568-573.
133. Rauch SL, Wedig MM, Wright CI, Martis B, McMullin KG, Shin LM et al (2007). Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 61: 330-336.
134. Reimold M, Smolka MN, Zimmer A, Batra A, Knobel A, Solbach C et al (2007). Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severityFa [11C]DASB PET study. J Neural Transm 114: 1603-1609.
135. Robinson D, Wu H, Munne RA, Ashtari M, Alvir JM, Lerner G et al (1995). Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 52: 393-398.
136. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ (2000). Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39: 1096-1103.
137. Ruck C, Karlsson A, Steele JD, Edman G, Meyerson BA, Ericson K et al (2008). Capsulotomy for obsessive-compulsive disorder: long-term follow-up of 25 patients. Arch Gen Psychiatry 65: 914-921. A cautionary description of the potentially high burden of adverse effects after ablations of relatively large tissue volumes and/or repeated lesion procedures.
138. Samuels J, Nestadt G, Bienvenu OJ, Costa Jr PT, Riddle MA, Liang KY et al (2000). Personality disorders and normal personality dimensions in obsessive-compulsive disorder. Br J Psychiatry 177: 457-462. (Pubitemid 30835567)
139. Sawle GV, Lees AJ, Hymas NF, Brooks DJ, Frackowiak RS (1993). The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry 56: 1016-1019.
140. Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S et al (1999). Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsy-chopharmacology 21: 683-693. A seminal report of changes within putative OCD neurocircuitry after serotonin transporter inhibitors and of the potential predictive value of regional brain metabolism.
141. Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E et al (2004). Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 161: 1038-1048.
142. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N et al (2008). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33: 368-377. A key report emphasizing a focus on potential behavioral endophenotypes of response to DBS in depression.
143. Schwartz JM, Stoessel PW, Baxter Jr LR, Martin KM, Phelps ME (1996). Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53: 109-113. An influential paper delineating changes in regional brain metabolism after successful behavior therapy for OCD.
144. Shapira NA, Okun MS, Wint D, Foote KD, Byars JA, Bowers D et al (2006). Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry 77: 410-412.
145. Steketee G, Chambless DL, Tran GQ (2001). Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Compr Psychiatry 42: 76-86. (Pubitemid 32095068)
146. Stewart SE, Stack DE, Farrell C, Pauls DL, Jenike MA (2005). Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder. J Psychiatr Res 39: 603-609.
147. Summerfeldt LJ (2004). Understanding and treating incompleteness in obsessive-compulsive disorder. J Clin Psychol 60: 1155-1168.
148. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL et al (1992). Cerebral glucose metabolism in childhood onset obsessive-compulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry 49: 690-694.
149. Szeszko PR, Ardekani BA, Ashtari M, Malhotra AK, Robinson DG, Bilder RM et al (2005). White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry 62: 782-790. (Pubitemid 41002761)
150. Szeszko PR, Christian C, Macmaster F, Lencz T, Mirza Y, Taormina SP et al (2008). Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry 165: 1299-1307.
151. Tenney NH, Denys DA, van Megen HJ, Glas G, Westenberg HG (2003). Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. Int Clin Psychopharmacol 18: 29-33.
152. Valenstein ES (1986). Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness. Basic Books: New York.
153. van den Heuvel OA, Remijnse PL, Mataix-Cols D, Vrenken H, Groenewegen HJ, Uylings HB et al (2009). The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 132(Pt 4): 853-868.
154. van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ et al (2004). Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. Am J Psychiatry 161: 2201-2206.
155. van Kuyck K, Brak K, Das J, Rizopoulos D, Nuttin B (2008). Comparative study of the effects of electrical stimulation in the nucleus accumbens, the mediodorsal thalamic nucleus and the bed nucleus of the stria terminalis in rats with schedule-induced polydipsia. Brain Res 1201: 93-99.
156. van Kuyck K, Demeulemeester H, Feys H, De Weerdt W, Dewil M, Tousseyn T et al (2003). Effects of electrical stimulation or lesion in nucleus accumbens on the behaviour of rats in a T-maze after administration of 8-OH-DPATor vehicle. Behav Brain Res 140: 165-173.
157. Van Laere K, Nuttin B, Gabriels L, Dupont P, Rasmussen SA, Greenberg BD et al (2006). Metabolic imaging of anterior capsular stimulation in refractory obsessive compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nuc Med 47: 740-747. A study finding that subgenual cortex activity before surgery might have predictive value in patients undergoing DBS for OCD.
158. Vitek JL (2002). Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord 17(Suppl 3): S69-S72.
159. Vogt BA, Pandya DN (1987). Cingulate cortex of the rhesus monkey; II. Cortical afferents. J Comp Neurol 262: 271-289.
160. Waziri R (1990). Psychosurgery for anxiety and obsessive-compulsive disorders. In: Burrows, Noyes, Roth (eds). Handbook of Anxiety: The Treatment of Anxiety. Elsevier: Amsterdam. pp 519-535.
161. Westenberg HG, Fineberg NA, Denys D (2007). Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 12(2 Suppl 3): 14-27.
162. Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE et al (2008). Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 165: 335-341; quiz 409.
163. Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR et al (2008). A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Hum Mol Genet 17: 717-723.
164. Woerdeman PA, Willems PW, Noordmans HJ, Berkelbach van der Sprenkel JW, van Rijen PC (2006). Frameless stereotactic subcaudate tractotomy for intractable obsessive-compulsive disorder. Acta Neurochir (Wien) 148: 633-637; discussion 637.
165. Yaryura-Tobias JA, Bebirian RJ, Neziroglu F, Bhagavan HN (1977). Obsessive compulsive disorders as a serotonergic defect. Res Commun Psychol, Psychiat and Beha 2: 279-286.
166. Zald DH, Kim S-W (1996). Anatomy and function of the orbital frontal cortex, I: Anatomy, neurocircuitry, and obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 8: 125-138.
167. Zald DH, Kim SW (2001). The orbitofrontal cortex. In: Salloway SP, Malloy PF, Cummings JL (eds). The Frontal Lobes and Neuropsychiatric Illness. APA Press: Washington. pp 33-69.